Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aptinyx Inc
(NQ:
APTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptinyx Inc
< Previous
1
2
3
4
5
6
Next >
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Via
Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
March 02, 2022
Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported...
Via
Benzinga
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia
February 28, 2022
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Hosts Virtual Portfolio Review Event to Showcase NYX-2925 in Chronic Pain and Provide Update on Clinical Development Programs
February 09, 2022
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 08, 2022
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Announces Formation of Scientific Advisory Board
February 03, 2022
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Highlights Key Goals and Anticipated Development Milestones for 2022
January 06, 2022
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Host Virtual Portfolio Review Event on February 9th, 2022
December 20, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Initiates Phase 2b Study of NYX-783 in Patients with Post-Traumatic Stress Disorder
December 16, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 13, 2021
From
Aptinyx Inc.
Via
Business Wire
Mid-Afternoon Market Update: Nasdaq Falls Over 1%; Reata Pharmaceuticals Shares Plummet
December 09, 2021
Toward the end of trading Thursday, the Dow traded up 0.17% to 35,814.21 while the NASDAQ fell 1.13% to 15,608.30. The S&P also fell, dropping 0.28% to 4,688.20. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 08, 2021
Gainers Aptinyx (NASDAQ:APTX) shares rose...
Via
Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 06, 2021
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD
Via
Benzinga
Aptinyx to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
November 18, 2021
From
Aptinyx Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 16, 2021
Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8...
Via
Benzinga
Aptinyx Inc. (APTX) Q3 2021 Earnings Call Transcript
November 10, 2021
APTX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Aptinyx Reports Third Quarter 2021 Financial Results and Recent Highlights
November 09, 2021
From
Aptinyx Inc.
Via
Business Wire
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
October 27, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
October 25, 2021
From
Aptinyx Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 22, 2021
Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of their outstanding shares is at $49.8 million. T2...
Via
Benzinga
Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors
October 20, 2021
From
Aptinyx Inc.
Via
Business Wire
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference
September 20, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures
September 16, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
August 31, 2021
From
Aptinyx Inc.
Via
Business Wire
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.